HHS Secretary Alex Azar declared public health emergencies for Georgia and South Carolina on Sept. 2 in preparation for Hurricane Dorian.

In the U.S., heart disease has been the reigning top cause of death for a number of years, but cancer is quickly becoming the top killer in some high-income and upper-middle-income countries, according to a new study published in The Lancet.

As the Trump administration pushes forth plans to make electronic health records accessible through apps, medical organizations are pushing back, citing privacy concerns, according to The New York Times.

HHS has jumped into the fray over the ongoing investigation into e-cigarettes amid more than 200 lung disease injuries associated with vaping. As of Aug. 27, 215 possible cases of pulmonary illnesses, including one death, have been reported across 25 states. 

An executive who jumped ship from CVS Health to join Amazon’s online pharmacy business PillPack will not be allowed to take on his new role, according to a U.S. District Court judge who ruled the move violated a noncompete agreement.

Patients are looking for more online resources when it comes to healthcare, and there are plenty of marketing pitfalls for healthcare companies to fall in.

CMS is updating its Medicare Plan Finder for the first time in a decade.

A proposed settlement would see Purdue Pharma shell out between $10 billion and $12 billion to close thousands of lawsuits over the company’s role in the opioid abuse and overdose epidemic.

With nearly 200 vaping-related lung disease injuries and one death across the U.S., the CDC’s investigation into e-cigarette harms is highlighting just how unregulated the market is for these relatively new tobacco and marijuana products, Politico reported.

HHS will provide $23 million to drug manufacturer Merck to produce Ebola vaccine doses over the next year, the agency announced Aug. 21. 

Physician compensation increased by a median of 2.92% in 2018, according to a new survey from AMGA Consulting. That’s a big jump from the 0.89% increase in compensation the previous year, reflecting that demand for healthcare professionals is driving higher pay.

Pharmaceutical, medical device and consumer packaged goods company Johnson & Johnson has been ordered to pay $572 million to the state of Oklahoma after a judge found the company downplayed the dangers of its opioid painkillers and contributed to the opioid overdose epidemic in the state.